Grand Pharma Receives Green Light for Phase III Trials of Cancer Drug
Grand Pharma Receives Green Light for Phase III Trials of Cancer Drug
Grand Pharma 获得 III 期抗癌药物试验的批准
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册